Continuing NPAT fell 6%; total NPAT down 28% on discontinued operation

The gap reflects a $40m after-tax loss recorded in discontinued operations, consistent with the consumer-business divestment activity flagged in the period.

Revenue from continuing operations fell 7.0% to $22.8b, while management reported operating profit (EBIT) from continuing operations of $1.6b. Cash generation was strong: operating cash flow of $2.3b and free cash flow of $1.6b after $577m of capex. The full-year ordinary dividend of 40.0c matched FY23, and the board added a 15.0c special dividend, taking the total declared return to 55.0c.

Continuing operations fell only 6.0% on both a PBT and after-tax basis, and the additional drag came from a disclosed $40m discontinued-operations loss rather than from core trading. For anyone reading the print, the 22.0pp gap between PBT growth and NPAT growth is almost entirely a presentation effect of exiting businesses, not a sign of core margin collapse.

Cash quality is the second key point. Free cash flow of $1.6b represents 140.3% of reported NPAT, meaning earnings converted to cash at a high rate even as the milk-price-driven revenue base contracted. That cash strength is what underpins the special dividend; on a pre-lease FCF basis the full 55.0c payout absorbs only 58.4% of free cash flow.

Segment economics show Greater China earning a derived 7.9% margin on $6.4b of revenue versus 5.6% for Global Markets at $16.8b. China is now the higher-quality earnings contributor on a per-dollar basis, which matters for how investors weight any future demand shift in that region.

Management commentary in the release describes the result as "significantly above 5-year average and above FY24 target range" and references an outlook range of 27–31, but the structured data does not anchor that figure to a specific metric, so it should not be read as confirmed guidance.

Against the HY24 marker of $674m NPAT, the implied second-half NPAT is around $454m — a softer second half consistent with weaker realised pricing through the year. The release does not provide enough forward context to judge whether that second-half shape persists into FY25.

FCF/NPAT of 140.3% is strong and signals that the earnings reported are not flattered by working-capital release in any way that would later reverse — capex of $577m (2.5% of revenue) was fully covered, leaving balance-sheet room for the special distribution. Return on equity of 13.8% on $8.2b of equity is a respectable through-cycle outcome given the revenue contraction.

On the earnings side, the 28.0% NPAT decline is partly a one-off effect of the discontinued operation, so the underlying durable read is closer to the 6.0% PBT decline. The dividend itself is well covered: the full 55.0c distribution sits at 82.1% of NPAT but only 58.4% of pre-lease FCF, so the special component is being funded from cash strength rather than from balance-sheet capacity. Gross borrowings of $3.4b and net debt of $2.9b frame leverage capacity for any further capital return tied to divestment proceeds.

This briefing cannot assess management's specific FY25 earnings guidance or divestment proceeds because neither is quantified in the supplied material.